Biohit: Medicinteknik företag med ingredienser för en vändning

Säker avkastning och enorm tillväxt? :scream:

Här är en färsk analys av ett intressant företag.

Biohit’s H2 exceeded our expectations in terms of growth and earnings were in line with our forecasts. Revenue growth was supported by positive development in various products and markets. We raise our revenue growth forecasts with the company’s good track record. We raise our earnings forecasts more moderately due to the increase in cost levels. The valuation picture has remained largely unchanged and the risk/reward ratio of the stock is attractive enough in our opinion to support a Buy recommendation.

image

2 gillningar